Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Soft Matter ; 20(4): 848-855, 2024 Jan 24.
Article in English | MEDLINE | ID: mdl-38170637

ABSTRACT

Nanocomposite hydrogels were elaborated that consisted of a physical network formed by an amphiphilic polymer in which C60 fullerene nanoplatelets were embedded. Characterization showed that the nanoplatelets within the polymer network were aggregated. The presence of these nanoplatelets led to an increase of the shear modulus of the hydrogels, that cannot be explained by a filler effect alone. The nanocomposite gels displayed similar rheological behavior, both in linear and non-linear domains, as neat hydrogels at higher polymer concentrations. We suggest that the particles reinforced the gels by forming additional connections between the polymer chains.

2.
J Palliat Care ; 35(1): 21-28, 2020 Jan.
Article in English | MEDLINE | ID: mdl-30898064

ABSTRACT

BACKGROUND: Respiratory distress protocols (RDPs) are protocolized prescriptions comprised of 3 medications (a benzodiazepine, an opioid, and an anticholinergic) administered simultaneously as an emergency treatment for respiratory distress in palliative care patients in the province of Quebec, Canada. However, data on appropriate use that justifies the combination of all 3 components is scarce and based on individual pharmacodynamic properties along with expert consensus. OBJECTIVES: Our study aimed to evaluate the conformity and the effectiveness of RDPs prescribed and administered to hospitalized adult patients. METHODS: This was a prospective and descriptive study conducted in a single center. Prescription and administration conformity were assessed based on predefined appropriateness criteria. RESULTS: A total of 467 adult patients were prescribed a RDP, 175 administrations were documented, and 78 patients received at least 1 RDP. Prescription conformity was assessed on 1473 separate occasions over the trial period. Overall prescription conformity was found to be 37% (95% confidence interval [CI]: 33.6-40.4), and administration conformity was 37.7% (95% CI: 26.2-50.7). Low administration conformity was primarily explained by incorrect indications for RDP use. Seemingly important determinants of higher conformity were prescriber's speciality in palliative care, use of preprinted orders, pharmacist involvement, and hospitalization in the palliative care unit. CONCLUSION: This study highlights important gaps in the use of RDPs in our institution. Health-care provider training appears necessary in order to ensure adequate conformity and allow for further evaluation of RDP effectiveness.


Subject(s)
Analgesics, Opioid/therapeutic use , Benzodiazepines/therapeutic use , Cholinergic Antagonists/therapeutic use , Palliative Care/standards , Prescription Drugs/standards , Respiratory Distress Syndrome/drug therapy , Tertiary Care Centers/standards , Aged , Aged, 80 and over , Analgesics, Opioid/standards , Benzodiazepines/standards , Cholinergic Antagonists/standards , Female , Guideline Adherence/statistics & numerical data , Humans , Male , Middle Aged , Practice Guidelines as Topic , Prospective Studies , Quebec , Tertiary Care Centers/statistics & numerical data
SELECTION OF CITATIONS
SEARCH DETAIL
...